Literature DB >> 21385154

ADME properties of herbal medicines in humans: evidence, challenges and strategies.

Shu-Ming He1, Eli Chan, Shu-Feng Zhou.   

Abstract

Herbal medicines, an important group of multicomponent therapeutics, are widely and increasignly used worldwide. Despite the popularitiy of herbal medicines, the clinical evidence that support the use of most herbal medicines is weak. Pharmacokinetic and absorption, distribution, metabolism and excretion (ADME) studies have been integrated into modern drug development, but ADME studies are generally not needed for herbal remedy discovery and development. For the majority of herbal medicines, data on their ADME and pharmacokinetic properties in humans are lacking or scant. An extensive literature search indicates that there are limited data on ADME properties of herbal medicines in humans. Many herbal compounds undergo Phase I and/or Phase II metabolism in vivo, with cytochrome P450s (CYPs) and uridine diphosphate glucuronosyltransferases (UGTs) playing a major role. Some herbal ingredients are substrates of P-glycoprotein (P-gp/MDR1/ABCB1) which is highly expressed in the intestine, liver, brain and kidney. As such, the activities of these drug metabolizing enzymes and drug transporters are critical determining factors for the in vivo ADME processes of herbal remedies. There are increasing ADME studies of herbal remedies, but these studies are mainly focused on a small number of herbal medicines including St John's wort, milk thistle, curcumin, echinacea, ginseng, ginkgo, and ginger. For an herbal medicine, the pharmacological activity is gained when the active agents or the active metabolites reach and sustain proper levels at their sites of action. Both the dose levels and ADME processes of active herbal components in the body govern their target-site concentrations and thus the therapeutic responses. In this regard, a safe and optimal use of herbal medicines requires a full understanding of their ADME profiles. To optimize the use of herbal remedies, further studies to explore their ADME properties in humans are certainly warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21385154     DOI: 10.2174/138161211795164194

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  21 in total

Review 1.  An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Authors:  Jiang Cheng; Zhi-Wei Zhou; Hui-Ping Sheng; Lan-Jie He; Xue-Wen Fan; Zhi-Xu He; Tao Sun; Xueji Zhang; Ruan Jin Zhao; Ling Gu; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

2.  Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an in silico study.

Authors:  Bhabani Shankar Das; Nabarun Chandra Das; Shasank Sekhar Swain; Suprabhat Mukherjee; Debapriya Bhattacharya
Journal:  Future Virol       Date:  2022-07-04       Impact factor: 3.015

3.  Anti hyperglycaemic study of natural inhibitors for Insulin receptor.

Authors:  Subhojyoti Chatterjee; Akshaya Lakshmi Narasimhaiah; Sanjay Kundu; Santosh Anand
Journal:  Bioinformation       Date:  2012-12-08

4.  Effect of a New Prokinetic Agent DA-9701 Formulated with Corydalis Tuber and Pharbitidis Semen on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.

Authors:  Hye Young Ji; Kwang Hyeon Liu; Ji Hyeon Jeong; Dae-Young Lee; Hyun Joo Shim; Miwon Son; Hye Suk Lee
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-02       Impact factor: 2.629

5.  Deep sequencing of plant and animal DNA contained within traditional Chinese medicines reveals legality issues and health safety concerns.

Authors:  Megan L Coghlan; James Haile; Jayne Houston; Dáithí C Murray; Nicole E White; Paula Moolhuijzen; Matthew I Bellgard; Michael Bunce
Journal:  PLoS Genet       Date:  2012-04-12       Impact factor: 5.917

6.  Schisandra chinensis regulates drug metabolizing enzymes and drug transporters via activation of Nrf2-mediated signaling pathway.

Authors:  Jin-Lian He; Zhi-Wei Zhou; Juan-Juan Yin; Chang-Qiang He; Shu-Feng Zhou; Yang Yu
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

7.  In vitro Effects of Four Native Brazilian Medicinal Plants in CYP3A4 mRNA Gene Expression, Glutathione Levels, and P-Glycoprotein Activity.

Authors:  Andre L D A Mazzari; Flora Milton; Samantha Frangos; Ana C B Carvalho; Dâmaris Silveira; Francisco de Assis Rocha Neves; Jose M Prieto
Journal:  Front Pharmacol       Date:  2016-08-19       Impact factor: 5.810

8.  New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics.

Authors:  Si-Yuan Pan; Shu-Feng Zhou; Si-Hua Gao; Zhi-Ling Yu; Shuo-Feng Zhang; Min-Ke Tang; Jian-Ning Sun; Dik-Lung Ma; Yi-Fan Han; Wang-Fun Fong; Kam-Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-24       Impact factor: 2.629

9.  Towards polypharmacokinetics: pharmacokinetics of multicomponent drugs and herbal medicines using a metabolomics approach.

Authors:  Ke Lan; Guoxiang Xie; Wei Jia
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-14       Impact factor: 2.629

10.  Evaluation of the transporter-mediated herb-drug interaction potential of DA-9801, a standardized dioscorea extract for diabetic neuropathy, in human in vitro and rat in vivo.

Authors:  Im-Sook Song; Tae Yeon Kong; Hyeon-Uk Jeong; Eun Nam Kim; Soon-Sang Kwon; Hee Eun Kang; Sang-Zin Choi; Miwon Son; Hye Suk Lee
Journal:  BMC Complement Altern Med       Date:  2014-07-17       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.